MTHFR and hyperhomocysteinemia: Mutations in the MTHFR gene reduce the enzymatic efficiency of homocysteine remethylation, leading to elevated circulating homocysteine levels, known as hyperhomocysteinemia (HHcy), a well-established risk factor for vascular dysfunction [35].